In the complex tumor microenvironment, PD-L1 can also be upregulated under the stimulation of different signaling pathways induced by inflammatory factors, such as gamma-interferon (IFN-γ), epidermal growth factor (EGF), and IL-17 (19). The gene discussed is EGF; the disease is neoplasm.